Vision Loss News and Research

RSS

Scientists discover underlying mechanisms of proptosis in patients with thyroid eye disease

Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have identified new underlying mechanisms of proptosis, or bulging of the eyes, in patients with acute thyroid eye disease.

18 Aug 2016

Children living in poor communities less likely to receive diagnosis for strabismus, study shows

Children are less likely to be diagnosed with crossed eyes, a condition known as strabismus, if they live in poor communities, according to an analysis led by researchers at the University of Michigan's Kellogg Eye Center.

17 Aug 2016

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases.

4 Aug 2016

USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant

Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.

30 Jul 2016

Researchers find potential way for delivering gene therapy to treat eye diseases

Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection.

27 Jul 2016

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.

21 Jul 2016

Are your sunglasses safe? An interview with Omar Hassan

All sunglasses that carry the CE mark block all UV rays, particularly if they're marked with the UV 400 label.

From Vision Express 19 Jul 2016

IU researchers create virtual tissue model of diabetic retinopathy

By combining data on optometry patient's eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye.

15 Jul 2016

New eye test could help detect glaucoma earlier than current techniques

UNSW Australia scientists have developed a testing protocol that identifies the blinding eye disease glaucoma four years earlier than current techniques.

12 Jul 2016

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.

11 Jul 2016

Scientists succeed in restoring multiple key aspects of vision in mice

Experiments conducted under the leadership of a Stanford University School of Medicine investigator have succeeded, for the first time, in restoring multiple key aspects of vision in mammals.

11 Jul 2016

Buck researchers find new way for possible treatment of AMD

Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans.

7 Jul 2016

Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Do you really need to get your eyes checked—even if you haven't noticed any vision problems or eye-related symptoms? More than half of routine eye examinations in asymptomatic patients lead to a change in vision prescription or other changes in care, according to a study in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

4 Jul 2016

Transorbital ACS can improve vision in patients with glaucoma, optic nerve damage

Vision loss due to glaucoma or optic nerve damage is generally considered irreversible. Now a new prospective, randomized, multi-center clinical trial demonstrates significant vision improvement in partially blind patients after 10 days of noninvasive, transorbital alternating current stimulation.

30 Jun 2016

Researchers investigate why N14Y, N14K mutations have distinct effects in KID syndrome patients

A team of New York-based researchers has compared the effects of two disease-causing mutations, potentially explaining why patients with the rare genetic disorder keratitis-ichthyosis-deafness (KID) syndrome can experience different sets of symptoms.

28 Jun 2016

Pain reliever appears to help preserve vision in animal model of retinal degeneration

A pain medicine that potently activates a receptor vital to a healthy retina appears to help preserve vision in a model of severe retinal degeneration, scientists report.

28 Jun 2016

Study estimates real-world prevalence of myopic choroidal neovascularization in the U.S.

A new study estimates that 9.6 million adults in the United States are highly myopic, or severely nearsighted. Of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer a complication called myopic choroidal neovascularization that could cause long-term vision loss, with women at higher risk.

22 Jun 2016